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Available online 14 November 2015Efﬁcient liposome disruption inside the cells is a key for success with any type of drug delivery system. The
efﬁcacy of drug delivery is currently evaluated by direct visualization of labeled liposomes internalized by cells,
not addressing objectively the release and distribution of the drug. Here, we propose a novel method to easily
assess liposome disruption and drug release into the cytoplasm. We propose the encapsulation of the cationic
dye Hoechst 34580 to detect an increase in blue ﬂuorescence due to its speciﬁc binding to negatively charged
DNA. For that, the dye needs to be released inside the cell and translocated to the nucleus. The present approach
correlates the intensity of detected ﬂuorescent dye with liposome disruption and consequently assesses drug
delivery within the cells.
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Liposome disruption1. Introduction
Over the past few decades, there has been increasing interest in
the use of liposomes for drug delivery. They represent one of the most
widely researchedmethods for improving circulation time, bioavailabil-
ity and targeting in numerous therapeutics [1,2]. Themaximumeffect of
a drug can only be achieved by strictly controlling its speciﬁcity for the
target cell.
However, other details of the drug delivery systems, such as efﬁcient
liposome disruptionwithin cells, are often technicallymore challenging.
Although drug behavior depends on the chemical properties of the com-
pound in question, its release is also affected by other factors. The nature
of individual liposomes as drug delivery systems, depends on physico-
chemical properties such as size, shape, and chemistry, all of which de-
termine the rate of disruption of the liposomes [3,4].
There is an increasing need to develop a system that can be used to
assess the disruption of the liposomes into the cell. Fluorescence can be
used to visualize labeled proteins, DNA and RNA in order to determineosphoethanolamine; DSPE–
0)-1,2-distearoyl-sn-glycero-
ine; PBS, phosphate buffered
gineering, University ofMinho,
lo).their release/localization in the cells [5]. The approach using labeled
compounds is not always straightforward as the constructs must be
developed. This process is time consuming and the detection limit is
usually low unless the ﬂuorescent materials aggregate or associated
with speciﬁc cellular components [6]. Furthermore, the ﬂuorescent
markers have been extensively used for tracking drug delivery [7–9]
but are not indicative of liposome disruption, not assuring release of
drugs in the cell cytoplasm.
Hoechst 34580 (N,N-Dimethyl-4-[5-(4-methyl-1-piperazinyl)[2,5′-
bi-1H-benzimidazol]-2′-yl]benzenamine trihydrochloride) (Fig. 1) is a
ﬂuorescent dye that is excited by ultraviolet light at 357 nm, and
emits blue/cyan ﬂuorescent light with an emission maximum at about
490 nm. Fluorescence is enhanced upon binding to double-stranded
DNA [10]. This bisbenzimidazole derivative is a supravital minor
groove-binding DNA stains with AT selectivity. The dyes bind to all
nucleic acids, but AT-rich double stranded DNA enhances the ﬂuores-
cence bymore than ~2-foldwhen compared to GC-rich strands [11]. Be-
cause of this increase in ﬂuorescence, Hoechst 34580 is used for the
quantiﬁcation of DNA and particularly for staining the nuclei of living
and ﬁxed cells.
In the present study, we intended to establish amethod to assess the
disruption of liposome drug delivery system in vitro using Hoechst
34580 as an imitating drug. The present approach enabled us to corre-
late the intensity of a ﬂuorescent dye with the disruption of the lipo-
some and consequent drug delivery in cell cytoplasm (Fig. 2).
Fig. 1. Chemical structure of Hoechst 34580.
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2.1. Materials
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), egg phos-
phatidylcholine (EPC) and N-(carbonyl methoxypolyethylene glycol-
2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE–MPEG)
were obtained from LipoidGmbH (Germany), andDSPE–PEG–FAwas ob-
tained from Avanti Polar Lipids (USA). Cholesterol and Hoechst 34580
were obtained from Sigma (USA). NucRed® Live 647 ReadyProbes®
was obtained from Invitrogen (USA).2.2. Liposome preparation
Liposomes composed of DOPE/EPC, cholesterol and DSPE–MPEG
(57: 38: 5, molar ratio) were prepared as previously described [12].
Brieﬂy, known amounts of DOPE/EPC, cholesterol and DSPE–MPEG
were dissolved in chloroform in a 50mL round-bottom ﬂask. The organ-
ic solvent was evaporated using a rotary evaporator followed by addi-
tional evaporation under reduced pressure by a high-vacuum system
to remove remaining traces of chloroform. The resultant dried lipid
ﬁlmwas dispersed in phosphate buffered saline (PBS) buffer containing
38 μg/mL Hoechst 34580. The mixture was vortex-mixed at a tempera-
ture greater than the phase-transition temperature (room temperature)
to yield multilamellar vesicles, which were then extruded (extruderFig. 2. Schematic representation of proposed methsupplied by Lipex Biomembranes Inc., Vancouver, Canada) through
200 nmpore size polycarbonate ﬁlters (Nucleopore) followed by sever-
al passages through 100 nm polycarbonate ﬁlters (Nucleopore) to form
large unilamellar vesicles. The dye not incorporated into liposomes was
removed from the samples after passage through a gel ﬁltration chro-
matography column (GE Healthcare).
2.3. Leakage assay
After 1week of preparation, liposomeswere subjected to a new pas-
sage through a gel ﬁltration chromatography column (GE Healthcare).
The eluate contain eventual free Hoechst 34580 dye, released from lipo-
somes, was collected. The following procedure was used to detect the
free dye, adapted from Silvander M. and Edwards K., 1996 [13]. The ini-
tial emission spectra from eluate collected after gel column separation
of liposomes was measured. The spectra of Hoechst 34580 was also
obtained, at the same concentration inside liposomes. Then DNA was
added in excess (5 mg/mL) to bind all free dye. The addition of DNA
brings about an enhanced ﬂuorescence intensity if free Hoechst 34580
is presented in solution, binding to supravital minor groove of DNA. A
Synergy Mx Multi-Mode Reader from BioTek (USA) was used to per-
form the ﬂuorescence measurements. Emission spectra was performed
after excitation at 357 nm.
2.4. Cell culture conditions
The human colonic epithelial cell line (Caco-2) (ATCC, HTB-37) was
obtained from the American Type Culture Collection. Cells were main-
tained in Dulbecco's modiﬁed Eagle medium (DMEM) containing
4 mM L-glutamine, 4.5 g/L glucose and 1.5 g/L sodium bicarbonate sup-
plemented with 10% (v/v) of fetal bovine serum (FBS), 1% (v/v) penicil-
lin/streptomycin solution and 1% (v/v) non-essentials amino acids. Cells
were maintained at 37 °C in a humidiﬁed atmosphere of 5% CO2. Caco-2
cells were routinely subcultured over 7 days, and the culture medium
was replaced every 2 days. Human peripheral blood mononuclear cells
were isolated from buffy coats of blood donors from the Immuno-
haemotherapy Department of Hospital de São João (Porto, Portugal)
by centrifugation over Lymphoprep (Axis-Shield), and monocytesod to simulate liposomal drug release in vitro.
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(Miltenyi Biotec). The ethics committee granted approval for the
study. Monocyte-derived macrophages were generated in RPMI 1640
(supplemented with 10% fetal calf serum, FCS, 100 U/mL penicillin and
100 μg/mL streptomycin) in the presence of 50 ng/mL macrophage
colony-stimulating factor (M-CSF, PeproTech) for 7 days followed by a
24 h activation with 20 ng/mL interleukin (IL)-4 (PeproTech).2.5. Confocal laser scanning microscopy
For liposomal internalization studies, Caco-2 cells were seeded at a
density of 5 × 105 cells per 500 μL perwell on 22mmcoverslips inserted
into the wells of 24-well tissue culture polystyrene (TCPS) plates (TPP).
After 10 days of adhesion, havingmedia refreshed every 2 days, theme-
dium was removed and cells were washed twice with PBS. Cells were
incubated with freshly prepared liposomes, encapsulating Hoechst
34580 at a phospholipid concentration of 100 μg/mL and diluted in
Hank's balanced salt solution (HBSS)medium. After 60min of exposure,
themediumwas removed, and cells were washed three timeswith acid
(pH 3.5) and neutral (pH 7.4) PBS at 4 °C to remove liposomes thatwere
not internalized. To NucRed® staining, 2 drops/mL of this reagent was
added, and after 15 min of incubation the cells were washed with PBS,
according to the manufacturer's instructions. The cells were then ﬁxed
with 4% paraformaldehyde for 30 min. Cells were further washed
three times with PBS. After drying, the coverslips were put on slides
coated with 2 μL of PermaFluor™ mounting medium (Thermo
Scientiﬁc™) and sealed. Slides were examined using an inverted Zeiss
confocal laser scanningmicroscope (Olympus Fluoview FV1000). Volume
rendering and 3D models were created with the software Imaris7.0
(Bitplane, Zurich, Switzerland).2.6. Cytometer analysis
The determination of ﬂuorescence intensity was assessed by ﬂow
cytometry analysis, using FACSCantoII from BD Biosciences. Brieﬂy,
cells were incubated for 15 and 60 min with 100 μg/mL of freshly
prepared liposomes in complete medium at 37 °C. Macrophages with-
out liposomes were used as negative control. After incubation, cells
were washed twice with PBS (pH 7.4) and then resuspended in PBS
for cytometry analysis. The internalization was determined as the
geometrical mean ﬂuorescence intensity of liposomes corrected
for the background staining of cells that were not incubated with lipo-
somes (negative control), and normalized to the uptake level of each
formulation.Fig. 3. Emission intensity spectra as detected after excitation at 357 nm, of (A) free dye Hoechs
preparation. Similar spectra was obtained to non pH-sensitive and pH-sensitive liposomes.2.7. Statistical analysis
Statistical analyses were performed with GraphPad Prism software
(version 5.0). Differences were tested for statistical signiﬁcance using
t-test, with p b 0.05 considered as signiﬁcant.3. Results and discussion
In this studywe used liposomal nanoparticles as these enclosed lipid
bilayers have gained extensive attention as carriers for a wide range of
drugs and applications. Their advantages include being both nontoxic
and biodegradable because they are composed of naturally occurring
substances [14]. In order to compare differences in membrane disrup-
tion, two types of liposomes were used: non pH and pH-sensitive. pH-
sensitive liposomes are stable at physiologic pH (pH 7.4) but undergo
destabilization and acquire fusogenic properties under acidic conditions
[15]. After liposomes enter cells via endocytosis, the acidic pH inside the
endosomes causes pH-sensitive liposomes to release their aqueous con-
tents into the cytoplasm, most likely by destabilizing the endosomal
membrane [16]. To acquire these pH-sensitive properties, liposomes
were prepared with the phospholipid DOPE, substituting phospholipid
EPC used in non pH-sensitive liposomes.
The inclusion of cholesterol and PEG-lipid in liposomal formulation
improves the ﬂuidity as well as the stability of bilayer membranes in
the presence of biological ﬂuids such as blood/plasma [17,18]. These
components reduce the permeability across themembrane ofwater sol-
uble molecules, decreasing undesired or too fast leakage rates. Adding
cholesterol to the liposome membranes reduced translational ﬂuidity
by ‘packing and ordering’ the bilayer [19,20]. PEG-lipids also increase
the lipid packing order and to reduce the leakage of encapsulated hy-
drophilic substances [21,22]. The leakage of hydrophilic substances
through a lipid bilayer is believed to occur via formation of defects
and/or transient pores in the membrane [23]. Membrane additives
that reduce the leakage may thus be assumed to reduce the occurrence
of defects and pores or, alternatively, to decrease the lifetime of these
structures [24]. In agreement, leakage of the dye Hoechst 34580 was
not observable in this liposomal formulation, as no quantiﬁable free
dye was detected during the ﬁrst week after preparation (Fig. 3). After
addition of DNA, the ﬂuorescence intensity of the eluates from
liposomes control and liposomes with encapsulated dye do not show
expressive diferences, indicating that there is no free dye in the eluate
collected after gel column separation (Fig. 3B).
It is known that despite the incorporation of PEG-lipid there is a sig-
niﬁcant decrease of pH-dependent release, although the efﬁcacy to pro-
mote intracellular delivery of their aqueous contents remains unalteredt 34580 and (B) eluate collected after gel column separation of liposomes, after 1 week of
Fig. 4. 3D representation of images obtained by confocal laser scanningmicroscopy. Images show the internalization and disruption of ﬂuorescent liposomal formulations (Hoechst 34580,
blue staining), by Caco-2 cells, with ﬂuorescent nucleus (NucRed®, red staining) after 60 min of incubation. The purple color, resulting from the overlay of two colors, indicates that the
Hoechst dye is located in the nucleus.
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of the PEG-lipid component, the dissociation of the PEG moiety and the
interaction with the endosomal membrane proteins might constitute
pertinent justiﬁcations [16].
In the present study we used encapsulated Hoechst 34580 dye to
evaluate the extent of liposomal membrane disruption to deliver
drugs intracellularly, through detection of an eventual increase in blue
ﬂuorescence due to the speciﬁc binding to DNA. We expected to detect
more quickly a higher blue ﬂuorescence in the nucleus of the cells incu-
bated with pH-sensitive liposomes, as their properties facilitate a faster
destabilization and disruption of their lipidic membrane. The images
obtained by confocal microscopy, represented here in 3D, showed that
Caco-2 cancer cells incubated with pH-sensitive liposomes clearly ex-
hibit stronger blue ﬂuorescence when compared with cells incubated
with non pH-sensitive liposomes (Fig. 4), indicating that they have a
better ability to release the encapsulated compounds. To prove the nu-
cleus localization of blue ﬂuorescence from Hoechst 34580 staining, a
far-red, cell-permeant nuclear stain, NucRed®, was also used in theFig. 5. Efﬁcient membrane disruption of pH-sensitive liposomes, comparing with non pH-sensi
after 15min and 60min of incubation. Graphs represent the relativemean ﬂuorescence intensit
liposomes after incubation at 37 °C. Values are the mean + SD of 2 experiments. Signiﬁcant dimicroscopy analysis. The overlay of the images obtained upon exposure
to both lasers, indicate that the blue ﬂuorescence, corresponding to
Hoechst labeling, coincides with the red ﬂuorescence fromNucRed® la-
beling, yielding a purple color (Fig. 4).
Fluorescence quantiﬁcation by ﬂow cytometry analysis indicate that
approximately 5 foldmore Hoechst related ﬂuorescence of pH-sensitive
liposomes was detectable in Caco-2 cells, relatively to those prepared
with EPC, after just 15 min of incubation (Fig. 5A). These results clearly
indicate that pH-sensitive liposomes are more efﬁciently disrupted in-
side Caco-2 cells than non pH-sensitive liposomes, and consequently
may quickly deliver vectorized compounds.
To corroborate the results obtained with the Caco-2 cancer
cell line, we also used primary macrophages derived from isolated
human peripheral blood monocytes. Compared with non pH-
sensitive liposomes, cells incubated with liposomes prepared with
DOPE showed higher blue ﬂuorescence levels (Fig. 5B). The ﬂuores-
cence intensity increased with time being more pronounced in non
pH-sensitive liposomes.tive, by (A) Caco-2 cells, after 15min of incubation, and (b) primary human macrophages,
y (MFI) determined by ﬂow cytometry analysis of Hoechst 34580 in cells with internalized
fferences were detected as shown by an asterisk (P b 0.05) and two asterisks (P b 0.005).
167E. Nogueira et al. / Biochimica et Biophysica Acta 1858 (2016) 163–167The results obtained in Caco-2 cancer cells and human primarymac-
rophages demonstrated the potential of this novelmethodology applied
to different cell types.
4. Conclusions
The present study successfully demonstrated that Hoechst 34580
incorporated in liposomal nanoparticles can be used to simulate drug
release into cells in vitro. The present approach can be extended to
other delivery systems toprovide objective information regardingparticle
disruption. Cell targeting and the biological effect of the drugs encapsulat-
ed may also be assessed using this innovative strategy.
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